Red Herring Editor Jumps Into New Overhyped Trend: Biotech
from the follow-the-hype-trail dept
Jason Pontin, former high profile editor of the now out of business Red Herring, has moved onto a new gig, as editor of a new magazine about the biotech industry. Yes, this sounds like someone moving from one overhyped industry into another - but Pontin insists he's learned his lessons from Red Herring, and the magazine, the Acumen Journal, won't make the same mistakes. It's easy to say that early on, of course.
1 Comments | Leave a Comment..
If you liked this post, you may also be interested in...
- If The RIAA Wants To Talk About Misinformation Campaigns, Let's Start With The RIAA's Misinformation Campaign
- UK Report Blames The Internet For Terrorism, Says ISPs Should Take Down Content
- NY Times: RIAA & MPAA Exaggerate Piracy Impact Stats... But We're Going To Assume They're True Anyway
- Author Jonathan Franzen Thinks That Ebooks Mean The World Will No Longer Work
- Misguided Twitter Protests... And Why Twitter Could Have Explained Itself Better





Reader Comments (rss)
(Flattened / Threaded)
Heh
In pharmaceutical research, 99.9% of research fails. The 0.1% that succeeds is handed off to production, so the researchers lose their jobs anyway. If you want to go into the biotech industry, you're looking at a life of bouncing from one failed company to the next. Unless you have a PhD in biology, and unless you think that squiggly molecules are the purpose of your life, it is not a fulfilling career.
[ reply to this | link to this | view in thread ]
Add Your Comment